Literature DB >> 8353495

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

J B Lichter1, C L Barr, J L Kennedy, H H Van Tol, K K Kidd, K J Livak.   

Abstract

The human dopamine D4 receptor contains a novel polymorphism within the putative third cytoplasmic loop of the protein. The polymorphism is characterized by a varying number of direct imperfect 48-bp repeats in the gene. Pharmacological characterization has suggested that this receptor is the site through which the atypical neuroleptic clozapine exerts its antipsychotic action and that some polymorphic variants display different pharmacological properties. Further analysis of the repeat region using innovative technologies indicates that the alleles vary not only in the number of repeats (2-8 or 10 repeat units) but also in the sequence of the repeats and the order in which they appear. In 178 unrelated chromosomes we have identified 19 different repeats in 25 different haplotypes coding for 18 different predicted amino acid sequences, making this one of the most variable functional proteins currently described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353495     DOI: 10.1093/hmg/2.6.767

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  105 in total

1.  Short tandem-repeat polymorphism/alu haplotype variation at the PLAT locus: implications for modern human origins.

Authors:  S A Tishkoff; A J Pakstis; M Stoneking; J R Kidd; G Destro-Bisol; A Sanjantila; R B Lu; A S Deinard; G Sirugo; T Jenkins; K K Kidd; A G Clark
Journal:  Am J Hum Genet       Date:  2000-09-13       Impact factor: 11.025

Review 2.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  A season-of-birth/DRD4 interaction predicts maximal body mass index in women with bulimia nervosa.

Authors:  Robert D Levitan; Allan S Kaplan; Caroline Davis; Raymond W Lam; James L Kennedy
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 4.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

5.  Differential Susceptibility: The Genetic Moderation of Peer Pressure on Alcohol Use.

Authors:  Amanda M Griffin; H Harrington Cleveland; Gabriel L Schlomer; David J Vandenbergh; Mark E Feinberg
Journal:  J Youth Adolesc       Date:  2015-08-26

6.  Temperament and externalizing behavior as mediators of genetic risk on adolescent substance use.

Authors:  Elisa M Trucco; Brian M Hicks; Sandra Villafuerte; Joel T Nigg; Margit Burmeister; Robert A Zucker
Journal:  J Abnorm Psychol       Date:  2016-02-04

7.  D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects.

Authors:  J Gelernter; H Kranzler; E Coccaro; L Siever; A New; C L Mulgrew
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

8.  Dopamine receptor D4 (DRD4) gene modulates the influence of informational masking on speech recognition.

Authors:  Zilong Xie; W Todd Maddox; Valerie S Knopik; John E McGeary; Bharath Chandrasekaran
Journal:  Neuropsychologia       Date:  2014-12-11       Impact factor: 3.139

9.  Interaction between prenatal stress and dopamine D4 receptor genotype in predicting aggression and cortisol levels in young adults.

Authors:  Arlette F Buchmann; Katrin Zohsel; Dorothea Blomeyer; Erika Hohm; Sarah Hohmann; Christine Jennen-Steinmetz; Jens Treutlein; Katja Becker; Tobias Banaschewski; Martin H Schmidt; Günter Esser; Daniel Brandeis; Luise Poustka; Ulrich S Zimmermann; Manfred Laucht
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

10.  Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample.

Authors:  Sarah W Feldstein Ewing; Heather A LaChance; Angela Bryan; Kent E Hutchison
Journal:  Addict Biol       Date:  2009-03-05       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.